Login to Your Account

ZZ Biotech's Stroke Therapy Shuns the Herd Mentality

By Marie Powers
Staff Writer

Tuesday, August 14, 2012

More than a decade after describing the anti-inflammatory, antithrombotic and neuroprotective effects of activated protein C (APC) in ischemic stroke and six years after forming a company to move that hypothesis toward treatment, ZZ Biotech LLC has advanced its initial compound, 3K3A-APC, into the clinic.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription